Join Rod Turner and three more expert speakers for an informal discussion about Regulation A+ (a new way for investors to invest in private companies) for an informal happy hour on March 15th in Los Angeles. Learn what makes Regulation A+ an attractive investment vehicle, legal implications, and more.
Register here for the 5 pm Happy Hour: Book Here Free
About this Event
Are you an early-stage investor in Biotech or Life Sciences? Jim Segermark, CEO of InsituBiologics will be pleased to answer your questions.
Are you a Biotech CEO that wants to learn more about Regulation A+ for raising capital in Biotech? Rod Turner will discuss Reg A+ and why it can be a good capital raising system for Biotech companies as well as an IPO vehicle.
Join us for casual conversation, drinks and appetizers Friday, March 15th from 5-7PM
Location
18 Social Lounge [Hotel Indigo]
899 Francisco Street
Los Angeles, CA 90017
Learn what makes Regulation A+ an attractive investment vehicle, legal implications, and more. Plus, network with other local companies and investors alike.
AGENDA:
5:00PM - 5:30PM Networking
5:30PM - 5:45PM Welcome / Introduction
5:45PM - 6:00PM Breakaway Session #1
6:00PM - 6:15PM Breakaway Session #2
6:15PM - 7:00PM Networking
EXPERTS:
Jim Segermark | Host; CEO, InSitu Biologics; insitubiologics.com
Rod Turner; CEO, Manhattan Street Capital; manhattanstreetcapital.com
Jillian Sidoti; Partner, Crowdfunding Lawyers; crowdfundinglawyers.net
Ron Reed, CEO, Maco.la Management, Inc. maco.la
Shahin Farshchi; Partner at Lux Capital VC Fund; San Francisco Bay Area (not at the Happy Hour)
PARTNERS:
California Life Sciences Association (CLSA) califesciences.org
Southern California Biomedical Council (SoCalBio) socalbio.org
About InSitu Biologics
InSitu Biologics is an emerging biotech company, with a highly developed non-opiate painkiller that is expected to be studied in people this year. Nearly $3m raised with Manhattan Street Capital using Regulation A+. www.insitubiologics.com
For more information contact
Jim Segermark, CEO of InSitu Biologics
1-651-338-4801 | [email protected]